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Abstract
AIM: To evaluate the capacity of 18F-fluorodeoxyglu-
cose positron emission tomography/computed tomog-
raphy (18F-FDG PET/CT) for detecting multiple primary 
cancer of upper gastrointestinal (UGI) tract. 
METHODS:  Fifteen patients (12 without cancer histo-
ries and 3 with histories of upper GI tract cancer) were 
investigated due to the suspicion of primary cancer of 
UGI tract on X-ray barium meal and CT scan. Subse-
quent whole body 18F-FDG PET/CT scan was carried 
out for initial staging or restaging. All the patients were 
finally confirmed by endoscopic biopsy or surgery. The 
detection rate of multiple primary malignant cancers 
was calculated based on 18F-FDG PET/CT and endo-
scopic examinations. 
RESULTS: 18F-FDG PET/CT scan was positive in 32 
suspicious lesions, 30/32 were true positive primary le-
sions, and 2/32 were false positive. In 15 suspicious 
lesions with negative 18F-FDG PET/CT scan, 12/15 were 
true negative and 3/15 were false negative. Among the 
15 patients, 12 patients had 29 primary synchronous 
tumors confirmed by pathology, including 8 cases of 
esophageal cancers accompanied with gastric cancer 
and 4 of hypopharynx cancers with esophageal cancer. 
The other 3 patients had 4 new primary metachronous 
tumors, which were multiple primary esophageal can-
cers. PET/CT imaging detected local lymph node metas-
tases in 11 patients. Both local lymph node metastases 
and distant metastases were detected in 4 patients. On 
a per-primary lesion basis, the sensitivity, specificity, ac-
curacy, negative predictive value and positive predictive 
value of 18F-FDG PET/CT for detecting multiple primary 
cancer of UGI tract were 90.9%, 85.7%, 89.4%, 80% 
and 93.7%, respectively.
CONCLUSION: The whole body 18F-FDG PET/CT may 
play an important role in evaluating the multiple pri-
mary malignant tumors of UGI tract cancer. 
© 2010 Baishideng. All rights reserved.
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INTRODUCTION
Metachronous or synchronous esophageal cancer has 
been identified in patients with head and neck cancer, 
gastric cancer or colon cancer[1]. Alcohol drinking and 
tobacco smoking are the major risk factors for upper 
aerodigestive tract cancers, accounting for a large propor-
tion of  cases in developed countries[2,3]. The occurrence 
of  multiple primary cancers in the aerodigestive tract has 
been explained by the concept of  field carcinogenesis. 
Combined exposure to alcohol and tobacco has a multi-
plicative effect on carcinogenesis of  upper aerodigestive 
tract[4,5]. 
X-ray barium meal examination, endoscopic examina-
tion, computed tomography (CT) are the main techniques 
used for the staging and follow-up of  upper gastrointesti-
nal (UGI) tract cancer[6,7]. However, the reported increase 
in sensitivity of  18F-fluorodeoxyglucose positron emission 
tomography/computed tomography (PET/CT) over CT 
has been attributed to the capacity of  18F-FDG PET/CT 
to detect metabolic abnormalities that precede the mor-
phological changes seen by CT. This study was under-
taken to further define the value of  18F-FDG PET/CT in 
evaluating multiple primary metachronous or synchronous 
cancer of  UGI.
MATERIALS AND METHODS
Patients
Fifteen patients with multiple UGI tract cancer (13 males 
and 2 female, aged 49-78 years with a mean age of  61 
years) were selected for a retrospective review from our 
electronic database, who were imaged by 18F-FDG PET/
CT between January 2007 and January 2010 because of  
the suspicious findings for multiple UGI tract cancer by 
the X-ray barium meal and endoscopic examinations. All 
the patients were finally confirmed by endoscopic biopsy 
or surgery.
18FDG PET/CT technique
The patients were asked to fast for at least 4 h before 
undergoing 18F-FDG PET/CT. Their blood glucose 
level should be within the normal range (70-120 mg/dL) 
prior to intravenous injection of  18F-FDG. The patients 
received an intravenous injection of  370-666 MBq (10- 
18 mCi) of  18F-FDG. Data acquisition by an integrated 
PET/CT system (Discovery STE; GE Medical Systems, 
Milwaukee, WI, USA) was performed within 60 min after 
injection. The procedure of  data acquisition was as fol-
lows: CT scanning was performed first, from the head 
to the pelvic floor, with 110 kV, 110 mA, a tube rotation 
time of  0.5 s, a 3.3-mm section thickness, which was 
matched to the PET section thickness. Immediately after 
CT scanning, a PET emission scan covering the identical 
transverse field of  view was obtained. Acquisition time 
was 3 min per table position. PET image data sets were 
reconstructed iteratively by applying the CT data for at-
tenuation correction, and coregistered images were dis-
played on a workstation.
PET/CT image interpretation 
The 18F-FDG PET/CT images were prospectively in-
terpreted by two experienced nuclear physicians. One 
had 21 years of  experience in both nuclear medicine and 
radiology, and the other had six years of  experience in 
both nuclear medicine and radiology, who read the 18F-
FDG PET/CT images on a high-resolution computer 
screen, and reached a consensus in cases of  discrepancy.
Based the knowledge of  the normal biodistribution 
of  18F-FDG, lesions were identified as foci with increased 
tracer accumulation relative to that in comparable normal 
contralateral structures and surrounding soft tissues. The 
lesions were qualitatively graded as definitely or probably 
abnormal (categorized as representing a tumor) if  the 
accumulation of  18F-FDG was markedly to moderately 
increased. Diffuse and mildly increased activity or no in-
creased activity (in the case of  an abnormality identified 
on CT, but no corresponding abnormality was present on 
PET) was considered to be a normal or benign disease.
Statistical analysis
The results of  PET/CT were quantified using the follow-
ing definitions: accuracy [(true positive) + (true negative)/
(total patients)], sensitivity [(true positive)/(true positive + 
false negative)], specificity [(true negative)/(true negative 
+ false positive)], positive predictive value [(true positive)/
(true positive +false positive)], and negative predictive 
value [(true negative)/(true negative + false negative)].
RESULTS
Clinical presentation
At the time of  multiple primary lesions of  suspected 
UGI cancer, the mean age of  the patients was 61 years 
with a predominant tendency in men. Twelve men and 
one woman had heavy tobacco and alcohol consumption 
histories in this group of  patients. 
PET/CT is able to demonstrate the entire UGI tract 
in almost all patients, even following incomplete endo-
scopic examination due to obstructing upper esophageal 
tumors in 4 patients (Figure 1). PET/CT imaging is help-
ful to guide accurately localization of  lower esophageal 
lesions in the remaining patients.
PET/CT diagnosis
18F-FDG PET/CT scan was positive in 32 suspicious le-
sions, of  which 30 were true positive primary lesions and 
2 were false positive. Among 15 suspicious lesions with 
negative 18F-FDG PET/CT scan, 12 were true negative 
and 3 were false negative. 
On a per-primary lesion basis, sensitivity, specificity, 
accuracy, negative predictive value and positive predic-
tive value of  18F-FDG PET/CT in detecting multiple 
primary cancer of  UGI tract were 90.9%, 85.7%, 89.4%, 
80% and 93.7%, respectively.
Primary tumor, local lymph node metastases and distant 
metastases
Of  the 15 patients, 12 patients had 29 primary synchro-
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nous tumors confirmed by pathology (Table 1), includ-
ing 8 cases of  esophageal cancer combined with gastric 
cancer and 4 had hypopharynx cancer combined with 
esophageal cancer. The other 3 patients had 4 new pri-
mary metachronous tumors (Table 2 and Figure 2). 
PET/CT imaging detected local lymph node metas-
tases in 11 patients (Figure 3). Both local lymph node 
metastases and distant metastases were detected in 4 pa-
tients. 
Impact on clinical management  
Clinical treatment plans were changed in 11 (73.3%) pa-
tients after PET/CT examination. 18F-FDG PET/CT im-
aging-guided radiotherapy was performed in 11 patients. 
DISCUSSION
Synchronous cancers were predominantly located in the 
aerodigestive tract, primarily in the lung, head and neck 
and esophagus[8]. Kumagai et al[9] reported half  of  the 
patients with multiple upper aerodigestive tract squa-
mous cell carcinomas are initially seen with synchronous 
tumors. It is also believed that these second primary can-
cers arise independently following exposure to a com-
mon carcinogen by a process that has been called field 
cancerization[10]. At least 75% of  head and neck cancers 
are attributable to a combination of  cigarette smoking 
and alcohol drinking[11]. In our cases, 13 patients (86.7%) 
had heavy tobacco and alcohol consumption histories. 
Synchronous tumors of  UGI tract were detected in 12 
patients. Esophageal cancers combined with gastric can-
cer (53.3%) were most frequently seen in our study. 
Patients with primary head and neck malignancies 
have a 3%-7% yearly incidence of  second primary can-
cers. Most metachronous squamous cell carcinomas 
become manifest within 3 years[12]. Detection of  second 
primaries has an important impact on therapy. For the 
patients treated for advanced squamous cell carcinoma in 
the oral cavity or oropharynx during the first year after 
completion of  their curative treatment, routine surveil-
lance for detecting early locoregional recurrence, distant 
metastases, and second metachronous primary tumors is 
very important[13,14]. Due to the poor prognosis of  head 
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Figure 1  A 52-year-old man with synchronous multiple esophageal cancers. 
The first positron emission tomography/computed tomography (PET/CT) images 
revealed multiple hypermetabolic esophageal lesions and hypermetabolic supra-
clavicular, mediastinal lymph nodes (arrows in A, C, E). PET/CT imaging guided 
radiation plan (arrows in B). The second PET/CT images after 50Gy radiation 
treatment demonstrated shrinkage of lesions and decrease of fluorodeoxyglucose 







Figure 2  A 56-year-old woman with metachronous gastric cancer after 
esophageal cancer resection 5 years ago. Positron emission tomography/
computed tomography (PET/CT) displayed multi-retroperitoneal lymph node 
recurrence (arrow in A), which was later verified as esophageal cancer metas-
tasis (squamous cell carcinoma). PET revealed a small lesion at gastric tube, 
but endoscopy was negative (arrows in A, B, C, D). Third PET/CT showed an 
enlarged gastric  lesion, and endoscopic biopsy verified gastric tube cancer 
(adenocarcinoma) (arrows in E, F).
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and neck cancer, the data of  metachronous cancer of  
UGI tract were limited. In this study, 3 patients had 4 
primary metachronous tumors. The interval from first 
tumor to second tumor ranged from 5 to 10 years. 
In the majority of  follow-up protocols, radiologic and 
endoscopic evaluation has been proven to be useful in the 
early detection of  metachronous and recurrent neoplasms 
in the follow-up of  patients with previously treated carci-
nomas of  the ear, nose, and throat. Adequate staging of  
UGI cancer including CT and endoscopic ultrasonogra-
phy has been considered to be helpful for avoiding useless 
surgery[15,16]. However, more than 30% of  the distant me-
tastases have been reported to be radiographically occult 
with conventional diagnostic strategy and surgery. It has 
been still performed in a considerable number of  patients 
with distant metastases. Moreover, the overall survival af-
ter curative resection does not exceed 25%, with an overall 
median disease-free survival of  only 12 mo.
Conventional staging methods consisting of  both CT 
and EUS evaluate local unresectability or metastatic dis-
eases based on the anatomic alterations. Their low sensi-
tivity and low specificity were related to the low accuracy 
in determining a curative surgery, indicating the demand 
for a different approach[17,18]. In contrast to conventional 
anatomic imaging, PET can reveal metabolic alterations 
in tumor tissues. Most malignant tumors present a high 
uptake of  18F-FDG due to an increased anaerobic glycol-
ysis[19]. In our previous studies, 18F-FDG PET/CT was 
found to be valuable in detecting previously unknown 
metastases in esophageal cancer. Routinely performed 
18F-FDG PET/CT in the preoperative work-up of  these 
tumors may therefore reduce the number of  unnecessary 
surgical procedures[20].
There have been several investigations into the util-
ity of  18F-FDG PET or PET/CT in relation to multiple 
primary cancers detection. Major advantages of  the whole 
body 18F-FDG PET/CT are the capability to perform full-
body scan with the potential to detect local and distant 
metastases in one single examination and the possibility of  
distinguishing new active disease from scar or necrotic tis-
sues[21,22] since tumors with increased 18F-FDG uptake are 
more metabolically active and biologically aggressive[23,24]. 
The accurate staging of  multiple primary cancer of  
UGI tract is essential to select appropriate treatment and 
to anticipate disease progression. Conventional imaging 
methods that rely on detection of  the structural changes 
caused by tumors usually have limitations in determining 
the extent of  UGI, especially lymph node metastasis[25,26]. 
PET/CT is a fundamentally different imaging technique 
that identifies focal areas of  increased metabolism as-
sociated with malignancies. PET/CT is more sensitive 
than regular CT scan in determining regional and distant 
lymph node involvement in the squamous cell carcinoma 
as well as adenocarcinoma of  the esophagus. PET can 
play an important role in evaluating the pretreatment 
staging of  esophageal cancer[27,28]. A noteworthy finding 
in the present study is the high incidence of  100% (13/13) 
of  local lymph node metastases and distant metastases 
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Table 1  Characteristics of synchronous tumor in 12 patients
Sex/age (yr) PET/CT findings Endoscopic results
T T N M
F/61 EPC (lower) Cardiac Gastrohepatic  EPC (lower), cardiac
M/60 Hypopharynx EPC (mid, lower) Mediastinal  Hypopharynx
M/62 EPC (upper) EPC (lower) Supraclavicular  EPC (upper)
M/59 EPC (lower) Cardiac Mediastinal, gastrohepatic EPC (lower), cardiac
M/61 Hypopharynx EPC (mid) Right cervical  Hypopharynx
M/62 EPC (mid) Cardiac Gastrohepatic  EPC (mid), cardiac
M/78 EPC (lower) Pylorus Mediastinal, gastrohepatic Lung EPC (lower), pylorus
M/57 EPC (mid, lower) Cardiac Mediastinal, gastrohepatic Lung EPC (mid, lower) 
M/52 EPC (upper) EPC (mid, lower) Mediastinal, supraclavicular EPC (upper, mid)
M/62 EPC (mid, lower) Cardiac Mediastinal, gastrohepatic Liver EPC (mid, lower)
M/53 Hypopharynx EPC (mid, lower) Cervical, mediastinal, retroperitoneal Hypopharynx
M/60 EPC (upper) EPC (mid) Supraclavicular, mediastinal  EPC (upper, mid)
PET/CT: Positron emission tomography/computed tomography; EPC: Esophageal cancer.
Table 2  Characteristics of metachronous tumor in 3 patients
Sex/age (yr) PET/CT findings Endoscopic results
Primary Secondary N M
M/68 EPC resection 10 yr ago Hypopharynx Cervical Hypopharynx
M/49 GC resection 25 yr ago EPC (lower), Cardiac Supraclavicular  Lung EPC (lower), cardiac
F/63 EPC resection 5 yr ago Gastric tube cancer Retroperitoneal   Gastric tube cancer 
PET/CT: Positron emission tomography/computed tomography; EPC: Esophageal cancer; GC: Gastric cancer.
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detected by 18F-FDG PET/CT. Furthermore, clinical 
decisions of  treatment were changed in 11 patients after 
PET/CT examinations.
There are several limitations in this study. First, due 
to the retrospective feature of  the study, we did not get 
all of  the medical details for some of  the patients. There 
are also some disadvantages associated with PET/CT 
imaging. For example, small tumors might be undetected 
because partial-volume effects result in a falsely low 
measurement of  true 18F-FDG activity[29]. Another draw-
back of  PET/CT is that 18F-FDG frequently accumu-
lates in areas of  inflammation. Variable physiologic FDG 
uptake patterns and benign pathological causes of  18F-
FDG uptake can be specifically recognized and properly 
categorized in other instances[30].
The choice of  diagnostic techniques must be based on 
the site and histologic characteristics of  the synchronous 
tumors. Although 18F-FDG PET/CT may be the preferred 
technique for staging UGI cancer, it can not replace other 
techniques, such as Lugol chromoendoscopy, for detecting 
synchronous UGI cancer in high-risk populations[31].
Our results suggested that 18F-FDG PET/CT may 
be useful in evaluating the multiple primary malignant 
tumors of  UGI cancer. It may play an important role in 
the initial staging of  multiple synchronous or metachro-
nous UGI tract cancers. 
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